+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Medical Nutrition Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • November 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968672
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The medical nutrition market is evolving rapidly, shaped by changing demographics, emerging clinical needs, and significant advances in technology. As healthcare providers and industry leaders seek targeted nutritional solutions, understanding the drivers and strategic responses in this sector is critical for sustained growth.

Market Snapshot: Medical Nutrition Market Overview

The global medical nutrition market is experiencing strong momentum, with revenues forecast to grow from USD 50.39 billion in 2024 to USD 55.07 billion in 2025. Steady expansion at a CAGR of 9.89% is projected, with the market expected to reach USD 88.76 billion by 2030. This report offers a comprehensive analysis of growth catalysts, regional dynamics, and competitive positioning within this vital industry.

Scope & Segmentation

This research provides in-depth coverage of the medical nutrition market, analyzing trends, innovations, and business strategies across multiple dimensions:

  • Product Types: Enteral nutrition; oral nutritional supplements (including liquid, powder, and snack bars); parenteral nutrition.
  • Age Groups: Adults; geriatric; pediatric.
  • Distribution Channels: Offline providers (home healthcare, hospitals, independent pharmacies, rehabilitation centers, senior living); online channels (brand-owned stores and eCommerce platforms).
  • Applications: Cancer, cardiovascular diseases, diabetes, gastrointestinal diseases, neurological diseases, obesity and weight management, pediatric malnutrition, pulmonary diseases, renal failure, wound healing.
  • Regions Covered: Americas (North America and Latin America); Europe, Middle East & Africa (Western Europe, Middle East, Africa); Asia-Pacific (China, India, Japan, Australia, South Korea, and others).
  • Key Companies: Abbott Laboratories, Danone S.A., Baxter International Inc., Nestlé S.A., Fresenius Kabi AG, Tate & Lyle PLC, and additional listed industry leaders.
  • Emerging Technologies: Bioactive ingredient delivery, digital health solutions, personalized formulations, and advanced monitoring platforms for patient adherence and clinical outcomes.

Key Takeaways

  • Rising incidence of chronic and lifestyle-related conditions is propelling demand for disease-specific nutritional interventions across all major regions.
  • Personalized nutrition and precision-medicine approaches are enabling clinicians to match therapies to individual patient profiles, supporting superior clinical management.
  • Healthcare providers are increasingly adopting hybrid nutrition products that combine pharmaceutical-grade actives with specialized nutrient matrices, accelerating product innovation.
  • Technological advancements are streamlining supply chain management and facilitating real-time monitoring of therapeutic adherence and outcomes.
  • Strategic collaborations between food science and pharmaceutical firms are expanding product pipelines, enabling wider clinical adoption and faster entry into new markets.
  • The market is segmented into niche segments with distinct requirements: adults for chronic disease, geriatrics for fortified solutions, and pediatrics for precision blends, enhancing product targeting and commercial strategy.

Tariff Impact: Navigating US Trade Policy in 2025

Recent US tariff policies have influenced raw material and component sourcing within the medical nutrition value chain. Manufacturers have responded by renegotiating contracts, seeking alternative suppliers, and implementing tariff mitigation strategies. These initiatives ensure business continuity while maintaining product affordability, ensuring continued supply chain resilience for all stakeholders.

Research Methodology & Data Sources

This report synthesizes findings from extensive stakeholder interviews, market data analysis, and peer-reviewed sources. It integrates both qualitative and quantitative research, drawing from clinician insight, corporate financial reviews, supply chain databases, and secondary literature to create a robust, validated perspective on the medical nutrition market.

Why This Report Matters for Decision-Makers

  • Informs investment and product development strategies by revealing nuanced trends and actionable segmentation within the medical nutrition industry.
  • Provides analysis of regulatory, technological, and market risks, enabling leaders to adapt quickly in a dynamic, compliance-driven environment.
  • Highlights collaborative innovations, hybrid approaches, and emerging opportunities for growth through localized and globalized business models.

Conclusion

The medical nutrition sector is marked by continuous innovation, clinical integration, and agile responses to evolving care standards. Leaders equipped with insights from this analysis can confidently accelerate business growth, optimize operations, and align strategies to market realities in a dynamic healthcare landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of personalized nutrition solutions into oncology patient care pathways
5.2. Rising demand for plant-based medical nutrition formulas in pediatric applications
5.3. Expansion of telehealth platforms driving remote monitoring of clinical nutrition
5.4. Development of microbiome-targeting supplements for metabolic syndrome management
5.5. Adoption of AI-driven dietary assessment tools in hospital nutritional therapy programs
5.6. Growth of high-protein oral supplements tailored for elderly sarcopenia prevention
5.7. Collaboration between nutraceutical companies and biotech firms on precision nutrition
5.8. Trends in regulatory harmonization for novel clinical nutrition ingredients across markets
5.9. Increase in high-calorie specialized tube-feeding products for critical care patients
5.10. Personalized microbiome-targeted medical nutrition therapies for gut health improvement
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Medical Nutrition Market, by Product Type
8.1. Enteral Nutrition
8.2. Oral Nutritional Supplements
8.2.1. Liquid
8.2.2. Powder
8.2.3. Snack Bars
8.3. Parenteral Nutrition
9. Medical Nutrition Market, by Age Group
9.1. Adults
9.2. Geriatric
9.3. Pediatric
10. Medical Nutrition Market, by Distribution Channel
10.1. Offline
10.1.1. Home Healthcare Providers
10.1.2. Hospitals
10.1.3. Independent Pharmacies
10.1.4. Rehabilitation Centers
10.1.5. Senior Living Facilities
10.2. Online
10.2.1. Brand-owned Online Stores
10.2.2. eCommerce Platforms
11. Medical Nutrition Market, by Application
11.1. Cancer
11.2. Cardiovascular Diseases
11.3. Diabetes
11.4. Gastrointestinal Diseases
11.5. Neurological Diseases
11.6. Obesity/Weight Management
11.7. Pediatric Malnutrition
11.8. Pulmonary Diseases
11.9. Renal Failure
11.10. Wound Healing
12. Medical Nutrition Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Medical Nutrition Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Medical Nutrition Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AAK India Private Limited
15.3.2. Abbott Laboratories
15.3.3. Ajinomoto Co., Inc.
15.3.4. Archer-Daniels-Midland Company
15.3.5. Arla Foods Ingredients Group P/S
15.3.6. B. Braun SE
15.3.7. BASF SE
15.3.8. Baxter International Inc.
15.3.9. Cargill, Incorporated
15.3.10. Danone S.A.
15.3.11. DSM-Firmenich AG
15.3.12. Evonik Industries AG
15.3.13. Fonterra Co-Operative Group Limited
15.3.14. Fresenius Kabi AG
15.3.15. FrieslandCampina Ingredients B.V.
15.3.16. Gelita AG
15.3.17. Glanbia PLC
15.3.18. Hexagon Nutrition Ltd.
15.3.19. Ingredion Incorporated
15.3.20. Kerry Group PLC
15.3.21. LABORATOIRES GRAND FONTAINE SLU
15.3.22. Lonza Group Ltd.
15.3.23. Medtrition, Inc.
15.3.24. Metagenics, LLC.
15.3.25. Nestlé S.A.
15.3.26. Perrigo Company PLC
15.3.27. Reckitt Benckiser Group
15.3.28. Tate & Lyle PLC
15.3.29. Usana Health Sciences, Inc.
15.3.30. Victus, Inc.

Companies Mentioned

The companies profiled in this Medical Nutrition market report include:
  • AAK India Private Limited
  • Abbott Laboratories
  • Ajinomoto Co., Inc.
  • Archer-Daniels-Midland Company
  • Arla Foods Ingredients Group P/S
  • B. Braun SE
  • BASF SE
  • Baxter International Inc.
  • Cargill, Incorporated
  • Danone S.A.
  • DSM-Firmenich AG
  • Evonik Industries AG
  • Fonterra Co-Operative Group Limited
  • Fresenius Kabi AG
  • FrieslandCampina Ingredients B.V.
  • Gelita AG
  • Glanbia PLC
  • Hexagon Nutrition Ltd.
  • Ingredion Incorporated
  • Kerry Group PLC
  • LABORATOIRES GRAND FONTAINE SLU
  • Lonza Group Ltd.
  • Medtrition, Inc.
  • Metagenics, LLC.
  • Nestlé S.A.
  • Perrigo Company PLC
  • Reckitt Benckiser Group
  • Tate & Lyle PLC
  • Usana Health Sciences, Inc.
  • Victus, Inc.

Table Information